The American Society for Clinical Pathology Board of Registry and The National Credentialing Agency for Laboratory Personnel have reached an agreement on the formation of a unified credentialing agency.
The US FDA has announced it has cleared for marketing a non-invasive test that uses molecular expression techniques to assist doctors in managing heart transplant patients post-surgery for potential organ rejection.
Signature Genomic Laboratories, a company that specializes in microarray-based diagnostic testing of genetic disease in individuals with mental retardation and birth defects, announced it has waived the 25% deposit previously required of patients for insurance billing.
DiagnoCure Oncology Laboratories has announced that it has received the US CLIA certification required for the Company to launch its new laboratory developed Previstage GCC Colorectal Cancer Staging Test. The sales team can now actively promote the test, and the Companys U.S. clinical laboratory can perform it and report patient results worldwide.
Scientists have discovered gene mutations that are the main cause of the inherited version of the childhood cancer neuroblastoma. In addition, the researchers found that the same mutations play a significant role in high-risk forms of non-inherited neuroblastoma, the more common form of the disease.
A study published in the September issue of Anesthesiology has identified a genetic mutation that could cause malignant hyperthermia. The goal of this research is to develop methods to identify patients with this disease so that these disastrous, rare consequences of certain anesthetics can be avoided.
Healthcare Providers Direct, Inc has introduced Colon Health Check, a self-administered diagnostic test that allows for quick, private and highly accurate screening for colon cancer at home. Colon Health Check detects the presence of blood in stool, and provides a negative or positive result to the test user within five minutes.
OralDNA Labs, Inc, a new specialty diagnostics company focused on advancing existing and future laboratory diagnostic capabilities as they are applied within oral medicine, has been launched.
Blood tests to check levels of the so-called sunshine vitamin are on the rise as doctors and patients react to headline-grabbing research that suggests having too little may not only hurt your bonesit might increase your risk of certain cancers or heart disease.
Biotest Diagnostics Corporation announces that it has received final clearance from the US Food and Drug Administration to begin marketing its full line of traditional blood bank reagents in North America.